Net profit of Astrazeneca Pharma India reported to Rs 29.09 crore in the quarter ended December 2018 as against net loss of Rs 10.35 crore during the previous quarter ended December 2017. Sales rose 67.41% to Rs 215.19 crore in the quarter ended December 2018 as against Rs 128.54 crore during the previous quarter ended December 2017.

Powered by Capital Market - Live News

Supreme Petrochem Ltd, Bombay Dyeing & Manufacturing Company Ltd, Westlife Development Ltd, Parag Milk Foods Ltd are among the other stocks to see a surge in volumes on BSE today, 07 February 2019.

Astrazeneca Pharma India Ltd clocked volume of 12854 shares by 10:49 IST on BSE, a 13.2 times surge over two-week average daily volume of 974 shares. The stock gained 13.01% to Rs.1,815.00. Volumes stood at 1814 shares in the last session.

Supreme Petrochem Ltd registered volume of 9671 shares by 10:49 IST on BSE, a 6.9 fold spurt over two-week average daily volume of 1403 shares. The stock rose 5.22% to Rs.207.70. Volumes stood at 773 shares in the last session.

Bombay Dyeing & Manufacturing Company Ltd saw volume of 5.75 lakh shares by 10:49 IST on BSE, a 3.99 fold spurt over two-week average daily volume of 1.44 lakh shares. The stock increased 10.48% to Rs.114.90. Volumes stood at 11730 shares in the last session.

Westlife Development Ltd recorded volume of 1.67 lakh shares by 10:49 IST on BSE, a 3.91 times surge over two-week average daily volume of 42663 shares. The stock gained 0.04% to Rs.367.85. Volumes stood at 5420 shares in the last session.

Parag Milk Foods Ltd saw volume of 1.16 lakh shares by 10:49 IST on BSE, a 3.63 fold spurt over two-week average daily volume of 31900 shares. The stock increased 3.16% to Rs.220.20. Volumes stood at 30331 shares in the last session.

Powered by Capital Market - Live News

The announcement was made after market hours yesterday, 6 February 2019.

Meanwhile, the S&P BSE Sensex was up 114.20 points, or 0.31% to 37,089.43

On the BSE, 2,113 shares were traded in the counter so far compared with average daily volumes of 900 shares in the past two weeks. The stock had hit a high of Rs 1,825 and a low of Rs 1,672 so far during the day.

AstraZeneca Pharma India's net sales rose 67.41% to Rs 215.19 crore in Q3 December 2018 over Q3 December 2017.

AstraZeneca Pharma India is the operating company covering manufacturing, sales and marketing activities. It has an innovative portfolio to address the unmet needs in non-communicable diseases such as diabetes, heart disease, cancer, asthma & COPD.

Powered by Capital Market - Live News

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 6 February 2019.

Powered by Capital Market - Live News